SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-17-020781
Filing Date
2017-12-15
Accepted
2017-12-15 16:19:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 navb20171205_s3.htm S-3 349346
2 EXHIBIT 4.9 ex_101577.htm EX-4.9 538766
3 EXHIBIT 5.1 ex_101571.htm EX-5.1 49085
4 EXHIBIT 23.2 ex_101572.htm EX-23.2 3908
5 EXHIBIT 23.3 ex_101573.htm EX-23.3 3105
6 a3.jpg GRAPHIC 12549
7 a2.jpg GRAPHIC 20266
8 a1.jpg GRAPHIC 23979
9 a4.jpg GRAPHIC 12829
  Complete submission text file 0001437749-17-020781.txt   1041187
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222092 | Film No.: 171259192
SIC: 2835 In Vitro & In Vivo Diagnostic Substances